Solventum Corporation (SOLV)
NYSE: SOLV · Real-Time Price · USD
76.62
+0.28 (0.37%)
At close: Apr 2, 2025, 4:00 PM
75.19
-1.43 (-1.87%)
After-hours: Apr 2, 2025, 7:55 PM EDT

Company Description

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally.

It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V.

site management, sterilization assurance, temperature management, surgical supplies, medical tapes and wrap, stethoscopes, medical electrodes, and medical technologies for original equipment manufacturers.

Its Dental Solutions segment provides a suite of dental and orthodontic products, including brackets, aligners, restorative cements, and bonding agents.

The Health Information Systems provides software solutions and services for health care systems, such as computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech recognition, and data visualization platforms.

Its Purification and Filtration segment provides purification and filtration technologies comprising filters, purifiers, cartridges, and membranes.

The company sells its products and services through direct-to-consumer, distribution, key account management, inside sales, and e-commerce.

Solventum Corporation was incorporated in 2023 and is based in Maplewood, Minnesota.

Solventum Corporation
Solventum logo
Country United States
Founded 2023
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 22,000
CEO Bryan Hanson

Contact Details

Address:
3M Center, Building 275-6W-20
Maplewood, Minnesota 55144-1000
United States
Phone 651 733 1110
Website solventum.com

Stock Details

Ticker Symbol SOLV
Exchange NYSE
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001964738
CUSIP Number 83444M101
ISIN Number US83444M1018
Employer ID 92-2008841
SIC Code 3841

Key Executives

Name Position
Bryan C. Hanson Chief Executive Officer and Director
Wayde D. McMillan Chief Financial Officer
Mary T. Wilcox Senior Vice President, Corporate Controller and Chief Accounting Officer
Amy Landucci Chief Information and Digital Officer
Marcela A. Kirberger Chief Legal Affairs Officer and Corporate Secretary
Tammy L. Gomez Chief Human Resources Officer
Paul S. Harrington Chief Supply Chain Officer
Karim Mansour President of Dental Solutions
Garri Garrison President of Health Information Systems
Mike Spears Senior Vice President of Regulatory Affairs and Quality Assurance

Latest SEC Filings

Date Type Title
Mar 21, 2025 ARS Filing
Mar 21, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 21, 2025 DEF 14A Other definitive proxy statements
Feb 28, 2025 IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012
Feb 28, 2025 10-K Annual Report
Feb 27, 2025 8-K Current Report
Feb 27, 2025 8-K Current Report
Dec 17, 2024 EFFECT Notice of Effectiveness
Dec 11, 2024 POS AM Post-Effective amendments for registration statement
Dec 10, 2024 4/A [Amend] Statement of changes in beneficial ownership of securities